FDA Takes Steps to Expand Testosterone for Men’s Libido
Heralding a “step forward on testosterone therapy for men,” the FDA announced an initiative to support a potential new indication of low libido in men due to idiopathic hypogonadism. The FDA will encourage drug companies with existing approved indications for testosterone replacement therapy (TRT) to contact the agency about the potential new indication. “New and…
